Skip to main content
Figure 4 | BMC Cancer

Figure 4

From: MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome

Figure 4

Kaplan-Meier plots comparing overall patient survival (X axis, in months) according to MAL2 (a, c) or TPD52 (b, d) expression status in stage III serous ovarian carcinomas. In panels a and b, patient cohorts are dichotomised at median MAL2 (a) or TPD52 (b) SPC values measured in the carcinoma cohort. In panels c and d, tumours with high-level cytoplasmic staining for MAL2 (c) or TPD52 (d), as determined by visual scoring, are compared with all others. In all panels, high-expressing cases are shown in black, whereas low-expressing cases are shown in grey. Numbers of patients compared in each arm, and associated p values (log rank tests) are indicated.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us